Clinical Laserthermia Systems AB (OSTO:CLS B) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CLS B Clinical Laserthermia Systems AB OSTO:CLS B
49 GF Score
Price kr1.85
GF Value kr2.57
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB FFO per Share?

FFO per Share only applies to REITs.

OSTO:CLS B
49GF Score
Clinical Laserthermia Systems AB OSTO:CLS B
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clinical Laserthermia Systems AB (OSTO:CLS B) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of kr1.85 is trading 28.1% below its estimated GF Value™ of kr2.57. GuruFocus considers Clinical Laserthermia Systems AB to be Modestly Undervalued.

Key valuation signals for OSTO:CLS B:

  • FFO per Share:
  • GF Value™: kr2.57 vs. price of kr1.85 (28.1% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the OSTO:CLS B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinical Laserthermia Systems AB Business Description

Other Exchanges LS60:Germany
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
49GF Score

Get the complete analysis for OSTO:CLS B

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.85
Price
kr2.57
GF Value